Navigation Links
UK Scientists to Reveal Genetic Secrets Behind Serious Illnesses

A team of UK scientists have undertaken what is described as the biggest DNA analysis of whole human genomes.//

Their findings will mark the biggest single leap in the understanding of how genes dictate our propensity to get ill, opening the door to a new wave of tailored therapies and tests to predict the likelihood that people will develop a serious illness.

A coalition of 50 groups, including 24 leading human geneticists, has completed a study which in the course of the next year will reveal genetic signposts for heart disease, diabetes, bipolar disorder and hypertension.

Over the coming months, the consortium will release similarly detailed findings in major journals for eight common illnesses. The researchers have analysed 19,000 DNA samples, which include 2,000 for people who suffer from each of the diseases and a control group of 3,000.

Separately, they are examining 15,000 markers for genetic variations relating to another four diseases - breast cancer, autoimmune thyroid disease, multiple sclerosis, and ankylosing spondylitis, a chronic swelling of the joints.

Cardiff psychiatrists taking part will reveal genetic variations which dictate the probability a person will develop bipolar disorder. "The genes will tell us which biological systems are involved and allow us to predict who is at risk," said Nick Craddock, leading the bipolar disorder research.

Mark Walport, director of the Wellcome Trust in the UK, which sponsors the programme, said: "This is the first time that anyone has been able to look at genetic variations at this scale - results for some other diseases are as important as those for obesity."

Genetic tests are currently available for specific genetic disorders, but the Wellcome Trust Case Control Consortium is looking at the more mild and multiple genetic variations which combine with environmental factors to give a person an increased risk of developing a disease.

Earlier this week Exeter and Oxford Universities revealed a genetic variation responsible for obesity carried by one in six people.

Those carrying one copy of the "fat" FTO gene had a 30 per cent increased risk of being obese compared to a person with no copies of that version, scientists found.

Those carrying two copies of the variant had a 70% increased risk of being obese, and were on average three kilos heavier than a similar person with no copies.

Peter Donnelly, Wellcome Trust consortium chair, said: "We are trying to identify the genetic factors which make some people more likely to develop a disease than others. We know genetics play a part but we haven't found the parts of the genome involved."

However, some scientists have pointed out that there are other, as yet undiscovered, genes involved in obesity, casting doubt on the usefulness of a test aimed at FTO alone.

Obesity is a complex disorder and there is no evidence from this research to suggest that carriers of the gene will not successfully lose weight by decreasing their energy intake and becoming more active, they have said.

They have further warned that genetic testing could be problematic where genes are identified before therapies exist, meaning that people could be told that they have a risk of developing an illness, but with no options to treat it.

There are also fears that testing will fuel the fledgling commercial market for genetic testing and that people will not receive the counselling required to react to a positive result for an illness. /V
'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... Based on ... safety and efficacy of HBOT in treating and helping to heal addictions and ... research showing the similarities of the wounds to the brain from traumatic brain ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... healthcare industry, made the 2017 Inc. 5000 with a three-year sales growth ... nation’s fastest-growing private companies and comprises the most comprehensive look at America’s independent ...
(Date:8/23/2017)... ... 2017 , ... MobilityWorks ®, the nation's largest retailer ... Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka WMK) ... the twelfth year that the company has been included on the list. , ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... the American Academy of Orthopaedic Surgeons , points out that therapeutic modalities ... from pain or injury. According to the report, a wider scope of physical ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology: